在健康男性中,HLX14的药理动力学,药理动力学,安全性和免疫性与参考代诺苏马布相比:一项随机的I期研究
Nanyang Li1, Nannan Chu2, Leilei Zhu3
1Clinical Pharmacology Research Center, Huashan Hospital, Fudan University, Shanghai, China.
Clinical and translational science
|December 19, 2024
概括
HLX14,一个拟议的denosumab生物类似剂,在中国的健康男性中显示出与denosumab的药理动力学,药理动力学,安全性和免疫性相似性. 这支持HLX14 .
科学领域:
- 生物制药产品 生物制药产品
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 德诺苏马布是一种用于治疗骨质疏松症的单克隆抗体.
- HLX14是一种拟用于denosumab的生物相似剂.
- 生物类似的发展需要严格的比较研究.
研究的目的:
- 为了比较HLX14与denosumab的药理动力学,药理动力学,安全性和免疫性.
- 评估HLX14作为中国健康成年人的潜在生物类似药.
主要方法:
- 一个随机的,平行组,两部分,I期研究.
- 60毫克HLX14或denosumab的皮下使用.
- 药物动力学终点包括AUC0-t,Cmax和AUC0-inf.
主要成果:
- 通过90%的置信区间在0.80-1.25的边际内证明了药物动力学相似性.
- 没有观察到药理动力学,安全性或免疫性方面的显著差异.
- HLX14表现出与参考denosumab非常相似的特征.
结论:
- 在药理动力学,药理动力学,安全性和免疫性方面,HLX14与登苏马布非常相似.
- 这些发现支持HLX14作为denosumab生物类似剂的进一步开发.
- HLX14代表了对骨质疏松症和骨质损失的有希望的治疗选择.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.4K
相关概念视频
01:21Pharmacodynamics: Overview and Principles
951
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
951
01:19Nonlinear Pharmacokinetics: Overview
268
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
268